ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
The NEO-CYT study, sponsored by Fondazione Melanoma Onlus, will be evaluating MDNA11 in front-line therapy for resectable ...
MedPage Today on MSN
CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma
Chimeric antigen receptor (CAR) T-cell therapy-associated immune-related adverse events (CirAEs) were associated with a high ...
5d
Medicenna Therapeutics Corp.: Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, ...
Background Both host and microbe metabolism of tryptophan (Trp) is altered in diabetes; however, the molecular mechanisms are ...
ImmunityBio, Inc. , a commercial-stage immunotherapy company, today announced updated efficacy and safety results from the ongoing QUILT-106 clinical study (NCT06334991) evaluating an off-the-shelf ...
A new study maps how prenatal stress alters immune signalling in the developing brain at a level of detail not seen before ...
A deep dive into the scientific shift toward multi-target obesity therapeutics and its implications for metabolic health and ...
Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...
3don MSN
Zvonimir Ivisic scores 18 points and Keaton Wagler adds 17 as No. 13 Illinois beats Minnesota 77-67
Zvonimir Ivisic scored 18 points and pulled down nine rebounds off the bench and Keaton Wagler had 17 points to lead No. 13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback